Price T Rowe Associates Inc Immunocore Holdings PLC Put Options Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
124Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$196 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$193 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$142 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$77.9 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA1.56MShares$45.4 Million3.45% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.28B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...